)
Visual
earnings real time
Processa Pharmaceuticals (PCSA) investor relations material
Processa Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Focused on developing Next Generation Cancer (NGC) therapies, with one drug in Phase 2 and another in preclinical development; also exploring out-licensing for non-oncology assets.
Announced a cryptocurrency treasury strategy to diversify capital and enhance financial flexibility, holding $850,000 in digital assets as of November 3, 2025.
Raised $10.6 million in public offerings during the nine months ended September 30, 2025, and additional funds through warrant exercises and private placements.
Financial highlights
Net loss of $3.4 million for Q3 2025, compared to $3.4 million in Q3 2024; net loss of $10.2 million for the nine months ended September 30, 2025, versus $9.1 million in the prior year period.
Operating expenses for Q3 2025: $1.7 million in R&D (down $0.6 million year-over-year), $1.8 million in G&A (up $0.7 million year-over-year).
Cash and cash equivalents of $6.3 million as of September 30, 2025; accumulated deficit of $97.4 million.
Used $8.5 million in cash for operating activities in the first nine months of 2025.
Outlook and guidance
Current cash, plus post-quarter warrant proceeds, expected to fund operations into Q1 2026; additional funding required for longer-term plans.
Plans to raise further capital through equity, debt, partnerships, or licensing; may use proceeds to acquire more digital assets.
Substantial doubt exists about ability to continue as a going concern beyond Q1 2026 without new funding.
Digital Assets funding clinical programs
PCS12852 licensing deal status and terms
Nasdaq compliance and going concern resolution
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Processa Pharmaceuticals earnings date
Q4 202526 Mar, 2026
Next Processa Pharmaceuticals earnings date
Q4 202526 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs. The company is engaged in the research and development of drug candidates aimed at addressing serious conditions across multiple therapeutic areas, including oncology and infectious diseases. Processa Pharmaceuticals' approach involves advancing its drug candidates through clinical trials to provide safer and more effective therapies. Its pipeline targets conditions where current treatment options may be limited or inadequate, aiming to improve patient outcomes and quality of life. The company is headquartered in Hanover, Maryland, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage